The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study



Status:Recruiting
Conditions:Cardiology, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:5/4/2018
Start Date:June 1, 2018
End Date:September 30, 2020
Contact:Ava Mayers
Email:ava.mayers@abbott.com
Phone:651-756-5576

Use our guide to learn which trials are right for you!

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study

FDA issued a Humanitarian Device Exemption (HDE) approval order for the AMPLATZER™ PIVSD
Occluder (H070005) on January 10, 2017. The Conditions of Approval require that SJM conduct a
post approval study to evaluate the safety and probable benefit of the AMPLATZER™ PIVSD
Occluder.

This is a multi-center, observational study to evaluate the safety and probable benefit of
the AMPLATZER™ PIVSD Occluder for use in transcatheter closure of muscular ventricular septal
defects following a myocardial infarction in the post approval setting.

The study has five endpoints (safety: acute and chronic survival; effectiveness: technical
success, acute and chronic closure).Two cohorts will be utilized to obtain study endpoint
data. The first cohort will be comprised of all available Emergency and Compassionate PIVSD
Occluder subject data from 2011 until the end of 2016 and these data will be used to
determine technical success and acute survival. The second cohort of thirty subjects will be
comprised of patients who are successfully implanted with a PIVSD Occluder from 2011 onward
at activated study centers. The index procedure must have occurred >6 months prior to
enrollment. Subject identification will occur until data on a minimum of 30 subjects with
PIVSD Occluders for post myocardial infarct VSD and post-procedure echocardiogram available
for evaluation of residual shunt by the echocardiography core laboratory have been enrolled.
The thirty subject cohort data will be used to determine acute closure, chronic closure, and
chronic survival endpoints.

The study will be conducted at up to 50 centers in the U.S. The expected duration of
enrollment is approximately 2 years. The total duration of the clinical study is expected to
be 2.5 years.

First Cohort:

Patients who have undergone an attempt to close a post-infarct VSD using the AMPLATZER™
PIVSD Occluder via Emergency and Compassionate 2011 until the end of 2016.

Second Cohort:

- Over 18 years old

- Patients who have previously been successfully implanted with the AMPLATZER™ PIVSD
Occluder

- Subject or subject's legally authorized representative has provided consent to
participate in this study

- Subject's post-procedure echocardiogram is evaluable and can be sent to the
echocardiography core laboratory for residual shunt assessment
We found this trial at
8
sites
9205 SW Barnes Rd
Portland, Oregon 97225
(503) 216-1234
Principal Investigator: Robert Hodson, MD
Phone: 503-962-1000
Providence St. Vincent Medical Center Providence St. Vincent is renowned for its many centers of...
?
mi
from
Portland, OR
Click here to add this to my saved trials
Durham, North Carolina 27710
(919) 684-8111
Principal Investigator: J. Kevin Harrison, MD
Phone: 919-613-4728
Duke University Younger than most other prestigious U.S. research universities, Duke University consistently ranks among...
?
mi
from
Durham, NC
Click here to add this to my saved trials
1 Cooper Plaza
Camden, New Jersey 08103
(856) 342-2000
Principal Investigator: Janah Aji, MD
Phone: 856-342-2057
Cooper University Hospital Cooper University Health Care, the clinical campus of Cooper Medical School of...
?
mi
from
Camden, NJ
Click here to add this to my saved trials
Cincinnati, Ohio 45220
Principal Investigator: Puvi Seshiah, MD
Phone: 513-862-2877
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
High Point, North Carolina 27262
Principal Investigator: Kurt Daniel, MD
Phone: 336-905-6284
?
mi
from
High Point, NC
Click here to add this to my saved trials
Marshfield, Wisconsin 54449
Principal Investigator: Milind Shah, MD
Phone: 715-387-5414
?
mi
from
Marshfield, WI
Click here to add this to my saved trials
4700 Alliance Boulevard
Plano, Texas 75093
Principal Investigator: Srinivasa Potluri, MD
Phone: 469-800-6416
?
mi
from
Plano, TX
Click here to add this to my saved trials
5300 Tallman Ave NW
Seattle, Washington 98122
(206) 782-2700
Principal Investigator: Sameer Gafoor, MD
Phone: 206-215-1500
Swedish Medical Center Since 1910, Swedish has been the region's hallmark for excellence in health...
?
mi
from
Seattle, WA
Click here to add this to my saved trials